Drug Type Small molecule drug |
Synonyms AZD 1236, AZD1236 |
Target |
Mechanism MMP12 inhibitors(Matrix metalloproteinase 12 inhibitors), MMP9 inhibitors(Matrix metalloproteinase 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 2 | CA | 01 Dec 2009 | |
Cystic Fibrosis | Phase 2 | NL | 01 Dec 2009 | |
Cystic Fibrosis | Phase 2 | PL | 01 Dec 2009 | |
Cystic Fibrosis | Phase 2 | ES | 01 Dec 2009 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | BG | 01 Sep 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | DK | 01 Sep 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | FI | 01 Sep 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | DE | 01 Sep 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | HU | 01 Sep 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | NL | 01 Sep 2008 |
Phase 2 | 55 | (AZD1236) | qjtsqmrvxm(dqqoksjmgq) = xvunalqehf ngmuixbmjl (volopbmmtn, zrflbiequg - jykxecihlj) View more | - | 16 Apr 2015 | ||
placebo (Placebo) | qjtsqmrvxm(dqqoksjmgq) = sctapwozlk ngmuixbmjl (volopbmmtn, yqzinsopjg - cosfsovcyk) View more |